Barbara Glover v. HHS - Influenza, transverse myelitis (2022)
Case summary [AI summaries can sometimes make mistakes]
Barbara Glover filed a petition on June 19, 2020, alleging that she developed transverse myelitis (TM) as a result of an influenza vaccine administered on October 18, 2018. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused Ms.
Glover's TM or any other injury. The parties reached a stipulation for compensation, which the Special Master adopted.
As part of the stipulation, Ms. Glover was awarded a lump sum of $70,000, representing compensation for all damages.
The parties agreed to this stipulation to resolve the case, with the respondent maintaining its denial of causation. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses.
The decision was issued by Special Master Nora Beth Dorsey on August 24, 2022.
Theory of causation
Petitioner Barbara Glover alleged that an influenza vaccine administered on October 18, 2018, caused her to develop transverse myelitis (TM). The influenza vaccine is listed on the Vaccine Injury Table. Respondent denied causation. The parties reached a stipulation for compensation, and the Special Master adopted the stipulation. Petitioner was awarded $70,000. The public decision does not detail the specific mechanism of injury, expert testimony, or other clinical information beyond the alleged condition and vaccine.
Source PDFs
USCOURTS-cofc-1_20-vv-00736